Effect of Fas+ and Fas- Target cells on the ability of NK cells to repeatedly fragment DNA and trigger lysis via the Fas lytic pathway

Apoptosis

Volumn 3, Issue 2, 1998, Pages 105-114

  Csipo, I ^a,b   Montel, A H ^a   Hobbs, J A ^a   Morse, P A ^a   Brahmi, Z ^a  

^a INDIANA UNIVERSITY   (United States)

^b UNIVERSITY OF DEBRECEN   (Hungary)

Author keywords

Apoptosis; DNA fragmentation; Fas lytic pathway; NK inactivation

Indexed keywords

EID: 2342558091     PISSN: 13608185     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1009696908600     Document Type: Article

References (37)

1. Robertson MJ, Ritz J. Biology and clinical relevance of human natural killer cells. Blood 1990; 79: 2421-2438.
2. Moretta A, Biassoni R, Bottino C, et al. Major histocompatibility complex, Class I-specific receptors on human natural killer and T lymphocytes. Immunol Rev 1997; 155: 105-117.
3. Raulet D, Held W. Natural killer cell receptors: The offs and ons of NC cell recognition. Cell 1995; 82: 697-700.
4. Lopez-Botet M, Moretta L, Stominger, J. NK-cell receptors and recognition of MHC Class I molecules. Immunol Today 1996; 17: 212-214.
5. Krahenbuhl O, Tschopp J. Involvement of granule proteins in T-cell-mediated lysis. Nat Immun Cell Growth Regul 1990; 9: 274-282.
6. Liu C-C, Walsh CM, Young JD-E. Perform structure and function. Immunol Today 1995; 16: 194-201.
7. Montel AH, Bochan MR, Hobbs JA, et al. Fas involvement in cytotoxicity mediated by NK cells. Cell Immunol 1995; 166: 236-246.
8. Oshimi Y, Oda S, Honda Y, et al. Involvement of Fas ligand and Fas mediated pathway in the cytotoxicity of human natural killer cells. J Immunol 1996; 157: 2909-2915.
9. Eischen CM, Schilling JD, Lynch DH, et al. Fc receptor induced expression of Fas-ligand and activated NK cells facilitates cell-mediated cytotoxicity and subsequent autocrine NK cell apoptosis. J Immunol 1996; 156: 2693-2699.
10. Nagata S, Goldstein P. The Fas death factor. Science 1995; 267: 1449-1456.
11. Suda T, Takahashi T, Goldstein P, et al. Molecular cloning and expression of the Fas ligand, a novel member of the tumor necrosis receptor family. Cell 1993; 75: 1169-1178.
12. McGahon A, Nishioka W, Martin S, et al. Regulation of the Fas apoptotic cell death pathway by Abl. J Biol Chem 1995; 270: 22625-22631.
13. Kagi D, Vignaux F, Ledermann B, et al. Fas and perforin pathways as major mechanisms of T cell-medicated cytotoxicity. Science 1994; 265: 528-530.
14. Lowin B, Kajne M, Mattman C, et al. Cytolytic T-cells cytotoxicity is mediated through perforin and Fas lytic pathways. Nature 1994; 370: 650-652.
15. Hahn S, Gehri R, Erb P. Mechanism and biological significance of CD4-mediated cytotoxicity. Immunol Rev 1995; 146: 57-59.
16. Isaaz S, Baetz K, Olsen K, et al. Serial killing by cytotoxic T lymphocytes: T cell receptor triggers degranulation, re-filling of the lytic granules and secretion of lytic proteins via a non-granule pathway. E J Immunol 1995; 25: 1071-1079.
17. Heusel J, Wesselschmidt R, Shresta S, et al. Cytotoxic lymphocytes require granzyme B for the rapid induction of DNA fragmentation and apoptosis in allogeneic target cells. Cell 1994; 76: 977-987.
18. Bellgrau D, Gold D, Selawry H, et al. A role for CD95 ligand in preventing graft rejection. Nature 1995; 377: 630-632.
19. Strassner A. Death of a T cell. Nature 1995; 373: 385-386.
20. Rieux-Laucat F, Le Deist F, Hivroz C, et al. Mutations in Fas associated with human lymphoproliferative syndrome and autoimmunity. Science 1995; 268: 1347-1349.
21. Abrams S I, Brahmi Z. Target cell directed NK inactivation. Concomitant loss of NK and antibody dependent cellular cytotoxicity activities. J Immunol 1988; 140: 2090-2095.
22. Hommel-Berrey GA, Shenoy AM, Brahmi Z. Receptor modulation and early signal transduction events in cytotoxic T lymphocytes inactivated by sensitive target cells. J Immunol 1991; 147: 3237-3243.
23. Bajpai A, Kwon BS, Brahmi Z. Rapid loss of perforin and serine protease RNA in cytotoxic lymphocytes exposed to sensitive target cells. Immunology 1991; 74: 258-264.
24. Bochan MR, Brahmi Z. Target cell-directed rapid degradation of TNF-α messenger RNA in human cytotoxic T cells. Immunol Lett 1994; 40: 37-42.
25. Goebel S, Schloemer R, Brahmi Z. Target cell-induced perforin mRNA turnover in NK3.3 cells is mediated by multiple elements within the mRNA coding region. Molecular Immunol 1996; 33: 341-349.
26. Kung S, Miller R. Mouse natural killer subsets defined by their target specificity and their ability to be separately rendered unresponsive in vivo. J Immunol 1997; 158: 2616-2626.
27. Dhein J, Walczak H, Baumler C, et al. Autocrin T-cell suicide mediated by APO-1 (Fas/CD95). Nature 1995; 373: 438-441.
28. Matzinger P. The JAM test: a simple assay for DNA fragmentation and cell death. J Immunol Methods 1991; 145: 185.
29. Abrams SI, Brahmi Z. The functional loss of human natural killer cell activity induced by K562 is reversible via an interleukin-2 dependent mechanism. Cell Immunol 1986; 101: 558-570.
30. Reiner NE. Altered cell signaling and mononuclear phagocyte deactivation during intracellular infection. Immunol Today 1994; 8: 374-381.
31. Brahmi Z, Bray RA, Abrams SI. Evidence for an early calcium independent event in the inactivation of the natural killer cell cytotoxic mechanism. J Immunol 1985; 135: 4108-4113.
32. Perussia B, Trinchieri G. Inactivation of natural killer cell cytotoxic activity after interaction with target cells. J Immunol 1981; 126: 754-758.
33. Heiskala MK, Carpen O, Saksela E. Mechanism of cell contact mediated inhibition of natural killer cell activity. J Immunol 1987; 139: 1414-1418.
34. Bajpai A, Brahmi Z. Target cell induced inactivation of cytolytic lymphocytes. Role and regulation of CD45 and calyculin A-inhibited phosphatase in response to interleukin-2. J Biochem 1994; 269: 18864-18869.
35. Bonavida B, Lebow LT, Jewett A. Natural killer cell subsets: maturation, differentiation and regulation. Nat Immunity 1993; 12: 194-208.
36. 2+-independent T cell-mediated cytotoxicity. J Exp Med 1993; 177: 195-200.
37. O'Connell J, O'Sullivan G.C., Collins JK, Shanahan F. The Fas counterattack: Fas-mediated T cell killing by colon cancer cells expressing Fas ligand. J Exp Med 1997; 184: 1075-1081.